, APAC

Howden Private Wealth announces new CEO for Singapore, Malaysia

A deputy CEO has also been appointed for Hong Kong.

Howden announced key promotions within its Private Wealth management team, with Bryan Pee and Shirley Sy stepping into new roles.  

Pee has been appointed Chief Executive Officer for Singapore and Malaysia, effective 10 March. 

Pee joined Howden in September 2023 as Head of the Singapore and Malaysia offices, following senior management roles at Credit Suisse. 

He has been credited with driving significant growth for Howden in the region. 

In his new position, Pee will oversee several teams and join Howden Private Wealth’s Executive Committee to help shape the division’s strategic direction.  

Sy has been promoted to Deputy Chief Executive Officer for Hong Kong, effective 1 January.

Sy, who joined Howden in 2011 as New Business Manager and became Head of Operations in 2014, has been integral to the company’s growth and operational success. 

She will continue to lead Hong Kong operations whilst also taking on partnership engagement responsibilities.

Howden Private Wealth has reported a 45% increase in policies written in 2024 and has placed over $50b in life insurance coverage globally, with more than $1.5b in new premiums annually.
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.